GPP
TTPH

Great Point Partners’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Great Point Partners’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,619
Closed -$1.73M – 42
2016
Q3 		$1.73M Sell
22,619
-92,357
-80% -$7.4M 0.44% 26
2016
Q2 		$9.89M Sell
114,976
-67,684
-37% -$6.2M 2.83% 13
2016
Q1 		$16.9M Buy
182,660
+85,660
+88% +$8.56M 6.07% 5
2015
Q4 		$19.5M Buy
97,000
+41,000
+73% +$8.18M 8.17% 5
2015
Q3 		$8.36M Buy
+56,000
New +$41.1M 3.3% 12

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Great Point Partners's TTPH Position: Q4 2016 in Review

Great Point Partners sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2016, closing a stake of 22,619 shares — an estimated $1.73M sold.

Great Point Partners first reported a position in TTPH in Q3 2015 and held it in 5 quarters. The position peaked at $19.5M in Q4 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

  • Great Point Partners reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Great Point Partners sold 22,619 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.73M.
  • Great Point Partners first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
  • Great Point Partners's Tetraphase Pharmaceuticals, Inc. position peaked at $19.5M in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on Great Point Partners's 13F filing for Q4 2016, filed 14 Feb 2017.